GGrantIndex
Sort

23,748 grants matching melanoma

Target metabolic vulnerabilities of MDSCs to enhance cancer immunotherapy

$208,581
Bin Zheng · Massachusetts General Hospital · R21 · FY2019 · CA

Autohistomagnetic Isolation of Tumor-reactive T-cells

$208,550
Adam William Mailloux · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2019 · CA

Mechanisms of concomitant tumor immunity and autoimmunity

$208,544
Mary J Turk · Dartmouth College · R01 · FY2014 · CA

Targeted nanotechnology for the pancreatic tumor immune microenvironment

$208,538
Martin G Pomper · Ut Southwestern Medical Center · P41 · FY2024 · EB

Proliferative effects of cdk4 and cdk6 dysregulation

$208,490
Tufts Medical Center · R01 · FY2003 · CA

Molecular Mechanisms of Metastasis Suppression by NM23

$208,422
David M Kaetzel · University Of Kentucky · R01 · FY2006 · CA

Parallel Selective Capture of Single Circulating Melanoma Cells and Integrated On-Chip Determination of Mutational Status

$208,313
Robbyn Kimberly Anand · Iowa State University · R21 · FY2019 · EB

Therapeutic potential of TCR-like recombinant antibodies

$208,288
Yoram Reiter · Technion-Israel Institute Of Technology · R01 · FY2006 · CA

A novel gene-based immunotherapy inducing melanoma destruction

$208,281
Katja Michael · University Of Texas El Paso · R21 · FY2025 · CA

Community Outreach and Engagement (COE)

$208,221
Jennifer Hatcher · University Of Arizona · P30 · FY2022 · CA

Administrative Core

$208,144
Meenhard Herlyn · Wistar Institute · P50 · FY2025 · CA

C-GMP CELL PROCESSING

$208,113
Leland H Hartwell · Fred Hutchinson Cancer Research Center · P30 · FY2007 · CA

A High-Throughput Model for Human Melanoma

$208,080
Sheri L. Holmen · Nevada Cancer Institute · R01 · FY2009 · CA

Core 2: Computational and Data Integration

$208,014
Kelly Valentine Ruggles · New York University School Of Medicine · U54 · FY2024 · CA

Modulating cancer progression by adipogenic human adenovirus type 36

$207,922
Lei Cao · Ohio State University · R21 · FY2013 · CA

Core A - Administrative

$207,905
Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2019 · CA

Genetic Mechanisms of Immunity and Inflammation in Melonoma Progression

$207,865
Jeffrey E Lee · University Of Tx Md Anderson Can Ctr · P50 · FY2013 · CA

Cancer Center Support Grant

$207,851
Cornelia M Ulrich · University Of Utah · P30 · FY2020 · CA

Southwest Oncology Group

$207,826
Lawrence E Flaherty · Wayne State University · U10 · FY2006 · CA

MI--A MASTER GENE FOR MELANOCYTE DEVELOPMENT

$207,713
Dana-Farber Cancer Institute · R01 · FY2000 · AR

FOLATE AMINOBORONIC ACIDS AS TARGETED ANTI-CANCER AGENTS

$207,675
Venkatram R Mereddy · University Of Minnesota Duluth · R15 · FY2008 · CA

MOLECULAR PREDICTIVE TESTING IN OCULAR MELANOMA

$207,551
James W Harbour · University Of Miami School Of Medicine · R01 · FY2013 · CA

Study of TCR Engineering Against Melanoma in Mice

$207,527
David Baltimore · California Institute Of Technology · P01 · FY2013 · CA

PROTEIN KINASE C SIGNALING IN APOPTOSIS AND SKIN CANCER

$207,352
Loyola University Chicago · R01 · FY2001 · CA

Project 2: Design and Development of Third Generation RXR Rexinoids as Potential Chemoprevention Agents

$207,303
Donald D Muccio · University Of Alabama At Birmingham · P01 · FY2019 · CA